Sanofi - Podomètre connecté / Portfolio

Progress does not happen overnight': Sanofi on evolution of medicine

Sanofi invests $180 million equity in Owkin's artificial intelligence and federated learning to advance oncology pipeline

How French pharma giant Sanofi is betting big on AI

Sanofi: French drugmaker Sanofi looks to spin off its consumer business in India - The Economic Times

How global healthcare leader Sanofi uses Twilio Segment to build golden profiles, increase omni-channel engagement, and improve patient outcomes

Sanofi CEO: Drugmaker must win over investors

Sanofi partners with TriNetX to speed drug development timelines

Digital and Data Science, we partner with cutting-edge innovators who share our ambition to empower people to live the life they want

Sanofi to license Innate Pharma's NK cell platform

Scientific Collaboration in North America

Portfolio - Sanofi

Advancing The Pediatric Vaccine Experience, WellChild Portfolio

Portfolio Sanofi Ventures

Sanofi Backs Out of Revolution Partnership in Latest Cancer Cull

Sanofi offloads 16 consumer health brands to Stada amid CEO Hudson's refocusing effort